Dr Anthony Kong
Laboratory Head at the Weatherall Institute of Molecular Medicine and an honorary NHS Consultant in Clinical Oncology at the Oxford Cancer Centre.
Email it
Your message will be:
Thought you might be interested in this page on Breakthrough Breast Cancer.
Anthony graduated from Barts and The London School of Medicine in 1997. After graduation, he did his general medical and oncology training at various hospitals including Barts and Royal Marsden Hospitals. He undertook a PhD in 2004 at the Cancer Research UK London Research Institute. Following his PhD, he spent several months doing clinical research at St Luc hospital in Brussels before resuming and completing his specialist training at the Royal Marsden Hospital in August 2008.
He took up a Clinician Scientist Fellowship, funded by Breakthrough Breast Cancer, at the University of Oxford on 1 Sept 2008. He is a Laboratory Head at the Weatherall Institute of Molecular Medicine and an honorary NHS Consultant in Clinical Oncology, specialising in breast cancer treatment at the Oxford Cancer Centre. The aims of Anthony’s group are to develop biomarkers for targeted therapies in breast cancer and to understand the mechanisms of resistance to targeted therapies in order to find new strategies to overcome resistance to these drugs.
"I am very thankful to Breakthrough Breast Cancer for awarding me a Clinician Scientist Fellowship. Without this fellowship, I would not be able to combine my translational research with clinical work".
